Allspring Global Investments Holdings LLC Buys 10,259 Shares of CompoSecure, Inc. (NASDAQ:CMPO)

Allspring Global Investments Holdings LLC increased its stake in CompoSecure, Inc. (NASDAQ:CMPOFree Report) by 67.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,430 shares of the company’s stock after purchasing an additional 10,259 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in CompoSecure were worth $164,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. bought a new position in shares of CompoSecure during the 1st quarter valued at $38,000. Raymond James Financial Services Advisors Inc. purchased a new position in CompoSecure in the first quarter worth about $76,000. BlackRock Inc. bought a new stake in shares of CompoSecure during the 1st quarter valued at about $835,000. Vanguard Group Inc. bought a new stake in shares of CompoSecure during the 1st quarter valued at about $1,506,000. Finally, Northern Trust Corp purchased a new stake in shares of CompoSecure during the 1st quarter valued at about $132,000. Institutional investors own 34.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. lowered shares of CompoSecure from an “overweight” rating to a “neutral” rating and cut their target price for the company from $7.00 to $6.00 in a research report on Monday, December 18th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, CompoSecure presently has an average rating of “Moderate Buy” and a consensus target price of $11.50.

Read Our Latest Report on CompoSecure

CompoSecure Stock Performance

Shares of NASDAQ CMPO opened at $5.22 on Wednesday. The company has a market cap of $414.05 million, a P/E ratio of 5.93 and a beta of 0.64. CompoSecure, Inc. has a 52-week low of $4.64 and a 52-week high of $7.90. The firm’s fifty day moving average is $5.24 and its two-hundred day moving average is $5.98.

CompoSecure (NASDAQ:CMPOGet Free Report) last issued its earnings results on Thursday, November 9th. The company reported $0.24 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.24. CompoSecure had a negative return on equity of 9.52% and a net margin of 4.62%. The firm had revenue of $96.89 million for the quarter, compared to analysts’ expectations of $101.52 million. As a group, analysts forecast that CompoSecure, Inc. will post 0.94 EPS for the current fiscal year.

Insider Activity at CompoSecure

In other CompoSecure news, major shareholder Lp Bleichroeder purchased 8,100 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The shares were bought at an average price of $4.88 per share, with a total value of $39,528.00. Following the completion of the purchase, the insider now directly owns 2,997,550 shares in the company, valued at $14,628,044. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 76.06% of the stock is currently owned by insiders.

CompoSecure Company Profile

(Free Report)

CompoSecure, Inc manufactures and designs metal, plastic, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Further Reading

Want to see what other hedge funds are holding CMPO? Visit to get the latest 13F filings and insider trades for CompoSecure, Inc. (NASDAQ:CMPOFree Report).

Institutional Ownership by Quarter for CompoSecure (NASDAQ:CMPO)

Receive News & Ratings for CompoSecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompoSecure and related companies with's FREE daily email newsletter.